What is a good cholesterol ratio?

A good cholesterol ratio is total cholesterol to HDL below 3.5:1, with optimal being under 3:1. The triglycerides to HDL ratio should be under 2:1, ideally below 1:1, as these ratios better predict cardiovascular risk than individual cholesterol numbers alone.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Cholesterol Ratios vs. Individual Numbers

When it comes to assessing cardiovascular health, cholesterol ratios often provide more meaningful insights than individual cholesterol numbers alone. While your doctor might discuss your total cholesterol, LDL (low-density lipoprotein), and HDL (high-density lipoprotein) levels separately, the relationships between these numbers—expressed as ratios—can better predict your risk of heart disease and stroke.

Think of cholesterol ratios as a way to understand the balance between protective and potentially harmful cholesterol in your bloodstream. HDL cholesterol acts like a cleanup crew, removing excess cholesterol from your arteries, while LDL cholesterol can contribute to plaque buildup when levels are too high. The ratio between these different types gives you a clearer picture of your cardiovascular risk profile.

If you're interested in understanding your complete cholesterol profile beyond basic testing, comprehensive biomarker testing can provide valuable insights into your cardiovascular health.

Cholesterol Ratio Risk Categories

These ratios should be interpreted alongside other cardiovascular risk factors and in consultation with your healthcare provider.
Ratio TypeOptimalGoodModerate RiskHigh Risk
Total Cholesterol:HDLTotal Cholesterol:HDLBelow 3:13:1 to 3.5:13.5:1 to 5:1Above 5:1
Triglycerides:HDLTriglycerides:HDLBelow 1:11:1 to 2:12:1 to 3:1Above 3:1
LDL:HDLLDL:HDLBelow 2:12:1 to 2.5:12.5:1 to 3.5:1Above 3.5:1
ApoB:ApoA1 (Men)ApoB:ApoA1 (Men)Below 0.70.7 to 0.80.8 to 0.9Above 0.9
ApoB:ApoA1 (Women)ApoB:ApoA1 (Women)Below 0.60.6 to 0.70.7 to 0.8Above 0.8

These ratios should be interpreted alongside other cardiovascular risk factors and in consultation with your healthcare provider.

The Most Important Cholesterol Ratios

Total Cholesterol to HDL Ratio

The total cholesterol to HDL ratio is calculated by dividing your total cholesterol by your HDL cholesterol. This ratio is one of the most commonly used markers for cardiovascular risk assessment. A lower ratio indicates a better balance between total cholesterol and the protective HDL cholesterol.

For optimal cardiovascular health, aim for a total cholesterol to HDL ratio below 3.5:1. Ratios above 5:1 are considered high risk, while ratios between 3.5:1 and 5:1 indicate moderate risk. The ideal target for most people is a ratio below 3:1, which suggests excellent cardiovascular health.

Triglycerides to HDL Ratio

The triglycerides to HDL ratio has emerged as a powerful predictor of insulin resistance and metabolic health. This ratio is particularly valuable because it reflects how well your body processes fats and sugars. High triglycerides combined with low HDL often indicate metabolic dysfunction that can lead to diabetes and heart disease.

An optimal triglycerides to HDL ratio is below 1:1, meaning your triglycerides are lower than your HDL cholesterol. Ratios below 2:1 are considered good, while ratios above 3:1 suggest increased risk for insulin resistance and cardiovascular disease. This ratio is especially important for identifying metabolic syndrome, even when other cholesterol numbers appear normal.

LDL to HDL Ratio

While less commonly discussed than the total cholesterol to HDL ratio, the LDL to HDL ratio provides specific insight into the balance between potentially harmful and protective cholesterol. This ratio helps assess how well your body is managing cholesterol transport and removal. An ideal LDL to HDL ratio is below 2.5:1, with ratios above 3.5:1 indicating increased cardiovascular risk.

Why Ratios Matter More Than Individual Numbers

Research has consistently shown that cholesterol ratios are better predictors of cardiovascular disease than individual cholesterol measurements. This is because ratios reflect the dynamic balance between different types of cholesterol and how they interact in your body. For example, someone with moderately high total cholesterol but very high HDL might have a better cardiovascular risk profile than someone with lower total cholesterol but very low HDL.

The Framingham Heart Study, one of the longest-running cardiovascular research projects, found that the total cholesterol to HDL ratio was a stronger predictor of heart disease than total cholesterol alone. Similarly, the triglycerides to HDL ratio has been shown to correlate strongly with insulin resistance, arterial stiffness, and the presence of small, dense LDL particles—all significant risk factors for cardiovascular disease.

Understanding your cholesterol ratios through regular monitoring can help you track your cardiovascular health more effectively than focusing on single biomarkers.

Advanced Markers: The ApoB to ApoA1 Ratio

Beyond traditional cholesterol ratios, the apolipoprotein B (ApoB) to apolipoprotein A1 (ApoA1) ratio represents the most advanced assessment of cardiovascular risk. ApoB is the primary protein component of LDL and other atherogenic particles, while ApoA1 is the main protein in HDL particles. Since each atherogenic particle contains one ApoB molecule, this measurement provides a direct count of potentially harmful particles rather than just their cholesterol content.

The ApoB to ApoA1 ratio is considered superior to traditional lipid ratios because it measures the actual number of atherogenic particles relative to protective particles. An optimal ApoB to ApoA1 ratio is below 0.7 for men and below 0.6 for women. Ratios above 0.9 for men and 0.8 for women indicate high cardiovascular risk. This advanced marker is particularly valuable for people with normal LDL cholesterol but elevated particle numbers.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Factors That Affect Your Cholesterol Ratios

Diet and Nutrition

Your dietary choices significantly impact cholesterol ratios. Consuming trans fats and excessive saturated fats can raise LDL and lower HDL, worsening your ratios. Conversely, incorporating healthy fats from sources like olive oil, avocados, and fatty fish can improve HDL levels and optimize your ratios. Soluble fiber from oats, beans, and vegetables helps lower LDL cholesterol, while excessive sugar and refined carbohydrates can increase triglycerides and worsen the triglycerides to HDL ratio.

Physical Activity and Exercise

Regular physical activity is one of the most effective ways to improve cholesterol ratios. Aerobic exercise increases HDL cholesterol while helping to lower triglycerides and LDL. Even moderate activity like brisk walking for 30 minutes daily can improve your ratios. High-intensity interval training (HIIT) has been shown to be particularly effective at improving the triglycerides to HDL ratio.

Genetics and Family History

Genetic factors play a substantial role in determining your cholesterol ratios. Familial hypercholesterolemia, for example, can cause very high LDL levels regardless of lifestyle. Some people naturally produce more HDL, while others may have genetic variants that affect how their body processes triglycerides. Understanding your genetic predisposition through family history and comprehensive testing can help you set realistic goals and determine if medication might be necessary.

How to Improve Your Cholesterol Ratios

Improving your cholesterol ratios requires a comprehensive approach that addresses both increasing protective HDL and managing LDL and triglycerides. Here are evidence-based strategies that can help optimize your ratios:

  • Increase omega-3 fatty acid intake through fatty fish, walnuts, and flaxseeds to raise HDL and lower triglycerides
  • Replace refined carbohydrates with whole grains and complex carbohydrates to improve triglyceride levels
  • Add 25-30 grams of soluble fiber daily from sources like oats, beans, and psyllium to lower LDL
  • Incorporate regular aerobic exercise and strength training to boost HDL and improve all ratios
  • Maintain a healthy weight, as even modest weight loss can significantly improve cholesterol ratios
  • Limit alcohol consumption to moderate levels, as excessive drinking can raise triglycerides
  • Consider plant sterols and stanols from fortified foods or supplements to help lower LDL
  • Manage stress through meditation, yoga, or other relaxation techniques, as chronic stress can worsen ratios

For those interested in tracking their progress and understanding how lifestyle changes affect their cholesterol ratios, regular biomarker testing provides valuable feedback on your cardiovascular health optimization efforts.

When to Consider Medical Intervention

While lifestyle modifications can significantly improve cholesterol ratios for many people, some individuals may need medical intervention to achieve optimal cardiovascular health. Consider discussing medication options with your healthcare provider if your total cholesterol to HDL ratio remains above 5:1 or your triglycerides to HDL ratio exceeds 3:1 despite consistent lifestyle changes for 3-6 months.

Statin medications are often the first-line treatment for improving cholesterol ratios, as they effectively lower LDL while modestly raising HDL. Other medications like fibrates can be particularly effective at lowering triglycerides and improving the triglycerides to HDL ratio. Newer medications like PCSK9 inhibitors can dramatically lower LDL and ApoB levels for those with genetic conditions or statin intolerance. The key is finding the right approach that addresses your specific ratio imbalances while considering your overall health profile and risk factors.

Monitoring Your Progress

Regular monitoring of your cholesterol ratios is essential for understanding whether your interventions are working. Most experts recommend checking your lipid panel every 3-6 months when making active lifestyle changes or adjusting medications. Once you've achieved stable, optimal ratios, annual testing may be sufficient unless you have additional risk factors.

When tracking your progress, pay attention to trends rather than single measurements. Cholesterol levels can fluctuate based on recent meals, stress, illness, and other factors. Looking at the pattern over multiple tests provides a more accurate picture of your cardiovascular health trajectory. Keep a log of your ratios along with notes about lifestyle changes, medications, and how you're feeling to identify what strategies work best for you.

For a comprehensive analysis of your existing cholesterol test results and personalized recommendations, you can use SiPhox Health's free blood test upload service to get AI-driven insights into your cardiovascular health markers and track your progress over time.

The Bottom Line on Cholesterol Ratios

Understanding and optimizing your cholesterol ratios provides a more complete picture of your cardiovascular health than focusing on individual cholesterol numbers. The most important ratios to monitor are your total cholesterol to HDL ratio (aim for below 3.5:1) and your triglycerides to HDL ratio (aim for below 2:1). For those seeking the most accurate assessment, the ApoB to ApoA1 ratio offers advanced insight into particle numbers rather than just cholesterol content.

Remember that improving cholesterol ratios is a gradual process that requires consistent effort. Focus on sustainable lifestyle changes including a heart-healthy diet, regular physical activity, stress management, and adequate sleep. Monitor your progress through regular testing, and don't hesitate to work with healthcare providers if you need additional support through medication or specialized interventions. With the right approach, most people can achieve cholesterol ratios that support long-term cardiovascular health and reduce their risk of heart disease.

References

  1. Millán, J., Pintó, X., Muñoz, A., Zúñiga, M., Rubiés-Prat, J., Pallardo, L. F., ... & Pedro-Botet, J. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Castelli, W. P. (1988). Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Canadian Journal of Cardiology, 4 Suppl A, 5A-10A.[PubMed]
  3. McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., ... & Krauss, R. M. (2005). Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? The American Journal of Cardiology, 96(3), 399-404.[PubMed][DOI]
  4. Walldius, G., & Jungner, I. (2006). The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. Journal of Internal Medicine, 259(5), 493-519.[PubMed][DOI]
  5. Gaziano, J. M., Hennekens, C. H., O'Donnell, C. J., Breslow, J. L., & Buring, J. E. (1997). Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96(8), 2520-2525.[PubMed][DOI]
  6. Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011). A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circulation: Cardiovascular Quality and Outcomes, 4(3), 337-345.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol ratios at home?

You can test your cholesterol ratios at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including HDL, LDL, triglycerides, ApoA1, and ApoB, allowing you to calculate all important ratios.

What is the most important cholesterol ratio to monitor?

The total cholesterol to HDL ratio is considered the most important for general cardiovascular risk assessment, though the triglycerides to HDL ratio provides valuable insight into metabolic health and insulin resistance.

How quickly can cholesterol ratios improve with lifestyle changes?

Most people see improvements in their cholesterol ratios within 4-8 weeks of consistent lifestyle changes, though significant improvements may take 3-6 months. The triglycerides to HDL ratio often improves faster than the total cholesterol to HDL ratio.

Are cholesterol ratios different for men and women?

While the target ratios are generally similar, women typically have higher HDL levels than men, which can result in better baseline ratios. The ApoB to ApoA1 ratio has slightly different optimal ranges, with women targeting below 0.6 and men below 0.7.

Can you have good cholesterol ratios but still be at risk for heart disease?

Yes, cholesterol ratios are just one aspect of cardiovascular risk. Other factors like blood pressure, inflammation markers (such as hs-CRP), family history, smoking status, and diabetes also play crucial roles in determining overall heart disease risk.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details